Onconetix Ownership 2024 | Who Owns Onconetix Now?


OverviewForecastFinancialsChart

Institutional Ownership

13.82%

Insider Ownership

17.69%

Retail Ownership

68.49%

Institutional Holders

21.00

Onconetix Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
RENAISSANCE TECHNOLOGIES LLC----56,400-100.00%-Mar 31, 2024
BANK OF NEW YORK MELLON CORP----25,926-100.00%-Mar 31, 2024
CITADEL ADVISORS LLC----50,272-100.00%-Mar 31, 2024
TWO SIGMA ADVISERS, LP----10,000-100.00%-Mar 31, 2024
O'DELL GROUP, LLC----115-100.00%-Mar 31, 2024

Onconetix's largest institutional shareholder is RENAISSANCE TECHNOLOGIES LLC, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
RENAISSANCE TECHNOLOGIES LLC----56,400-100.00%-Mar 31, 2024
BANK OF NEW YORK MELLON CORP----25,926-100.00%-Mar 31, 2024
CITADEL ADVISORS LLC----50,272-100.00%-Mar 31, 2024
TWO SIGMA ADVISERS, LP----10,000-100.00%-Mar 31, 2024
O'DELL GROUP, LLC----115-100.00%-Mar 31, 2024

The largest Onconetix shareholder by % of total assets is RENAISSANCE TECHNOLOGIES LLC. The company owns 0.00 shares of Onconetix (BWV), representing 0.00% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
O'DELL GROUP, LLC----115-100.00%-Mar 31, 2024
TWO SIGMA ADVISERS, LP----10,000-100.00%-Mar 31, 2024
BANK OF NEW YORK MELLON CORP----25,926-100.00%-Mar 31, 2024
CITADEL ADVISORS LLC----50,272-100.00%-Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC----56,400-100.00%-Mar 31, 2024

As of Mar 31 2024, Onconetix's largest institutional buyer is O'DELL GROUP, LLC. The company purchased -0.12K stocks of BWV, valued at -.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
RENAISSANCE TECHNOLOGIES LLC----56,400-100.00%-Mar 31, 2024
CITADEL ADVISORS LLC----50,272-100.00%-Mar 31, 2024
BANK OF NEW YORK MELLON CORP----25,926-100.00%-Mar 31, 2024
TWO SIGMA ADVISERS, LP----10,000-100.00%-Mar 31, 2024
O'DELL GROUP, LLC----115-100.00%-Mar 31, 2024

As of Mar 31 2024, Onconetix's biggest institutional seller is RENAISSANCE TECHNOLOGIES LLC. The company sold -56.40K shares of BWV, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
RENAISSANCE TECHNOLOGIES LLC----56,400-100.00%-Mar 31, 2024
CITADEL ADVISORS LLC----50,272-100.00%-Mar 31, 2024
BANK OF NEW YORK MELLON CORP----25,926-100.00%-Mar 31, 2024
TWO SIGMA ADVISERS, LP----10,000-100.00%-Mar 31, 2024
O'DELL GROUP, LLC----115-100.00%-Mar 31, 2024

Onconetix's largest sold out institutional shareholder by shares sold is RENAISSANCE TECHNOLOGIES LLC, sold -56.40K shares, valued at -, as of undefined.

Onconetix Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
VANGUARD INDEX FUNDS0.00%147,026-48,461-24.79%Dec 31, 2023
FIDELITY CONCORD STREET TRUST0.00%52,400--Feb 29, 2024
iSHARES TRUST0.00%16,680--Feb 29, 2024

Onconetix's largest mutual fund holder by % of total assets is "VANGUARD INDEX FUNDS", owning 147.03K shares, compromising 0.00% of its total assets.

Onconetix Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Dec, 232116.67%
30 Sep, 2318-
30 Jun, 231838.46%
31 Mar, 2313-27.78%
31 Dec, 221820.00%
30 Sep, 221587.50%
30 Jun, 228-38.46%
31 Mar, 2213-

As of 31 Dec 23, 21 institutions are holding Onconetix's shares, representing an increase of 16.67% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Dec, 232,421,823-32.08%
30 Sep, 233,565,69351.42%
30 Jun, 232,354,88045.35%
31 Mar, 231,620,167-16.32%
31 Dec, 221,936,159-17.87%
30 Sep, 222,357,568111.55%
30 Jun, 221,114,438143.56%
31 Mar, 22457,557-

Onconetix (BWV) has 2.42M shares outstanding as of 31 Dec 23, down -32.08% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Dec, 2313.82%2.75%
30 Sep, 2322.41%10.23%
30 Jun, 2314.80%14.27%
31 Mar, 2310.18%4.09%
31 Dec, 2215.78%5.84%
30 Sep, 2216.44%19.05%
30 Jun, 229.29%17.83%
31 Mar, 227.22%-

As of 31 Dec 23, Onconetix is held by 13.82% institutional shareholders, representing a 2.75% growth compared to 30 Sep 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Dec, 237-22.22%
30 Sep, 239-35.71%
30 Jun, 2314100.00%
31 Mar, 237-41.67%
31 Dec, 2212-7.69%
30 Sep, 221385.71%
30 Jun, 227-46.15%
31 Mar, 2213-

7 institutional shareholders have increased their position in BWV stock as of 31 Dec 23 compared to 9 in the previous quarter (a -22.22% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Dec, 23433.33%
30 Sep, 233-
30 Jun, 23350.00%
31 Mar, 232-50.00%
31 Dec, 224100.00%
30 Sep, 222-
30 Jun, 22--
31 Mar, 22--

4 institutional shareholders have reduced their position in BWV stock as of 31 Dec 23 compared to 3 in the previous quarter (a 33.33% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Dec, 232116.67%2,421,823-32.08%13.82%2.75%7-22.22%433.33%
30 Sep, 2318-3,565,69351.42%22.41%10.23%9-35.71%3-
30 Jun, 231838.46%2,354,88045.35%14.80%14.27%14100.00%350.00%
31 Mar, 2313-27.78%1,620,167-16.32%10.18%4.09%7-41.67%2-50.00%
31 Dec, 221820.00%1,936,159-17.87%15.78%5.84%12-7.69%4100.00%
30 Sep, 221587.50%2,357,568111.55%16.44%19.05%1385.71%2-
30 Jun, 228-38.46%1,114,438143.56%9.29%17.83%7-46.15%--
31 Mar, 2213-457,557-7.22%-13---

Onconetix Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jan 03, 2024Schiess Ralphofficer Chief Science OfficerSell---269,749
Dec 28, 2023Bruhlmann Christianofficer Chief Strategy OfficerSell---236,029
Oct 10, 2023CAMPBELL NEIL Jdirector, officer Chief Executive OfficerSell532,326$0.43$229.17K-
Oct 10, 2023Harmon Bruceofficer Chief Financial OfficerSell177,442$0.43$76.39K-
Apr 12, 2023Cincinnati Cornerstone Investors BWV I, LLC10 percent owner-J-OtherSell1,200,000--1,161,201
Nov 21, 2022Cincinnati Cornerstone Investors BWV I, LLCdirector-J-OtherSell750,000--2,361,201
Aug 29, 2022Cincinnati Cornerstone Capital LLCdirector J-OtherSell500,000--3,111,201

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jan 03, 2024Schiess Ralphofficer Chief Science OfficerSell---269,749
Dec 28, 2023Bruhlmann Christianofficer Chief Strategy OfficerSell---236,029
Oct 10, 2023CAMPBELL NEIL Jdirector, officer Chief Executive OfficerSell532,326$0.43$229.17K-
Oct 10, 2023Harmon Bruceofficer Chief Financial OfficerSell177,442$0.43$76.39K-
Jun 01, 2023Jeremic Vukdirector-A-AwardBuy6,360--6,360
Jun 01, 2023Ramdeen Timothy R.director-A-AwardBuy6,360--6,360
Jun 01, 2023Tarsh Simondirector-A-AwardBuy6,360--6,360
Jun 01, 2023SAPIRSTEIN JAMESdirector-A-AwardBuy6,360--6,360
May 11, 2023Hernandez Josephdirector, 10 percent owner, officer CEOA-AwardBuy150,000--2,800,351
May 11, 2023Garfield Jonofficer Chief Financial OfficerA-AwardBuy100,000--100,000
May 11, 2023Henderson Erinofficer Chief Business OfficerA-AwardBuy150,000--174,752
Apr 12, 2023Cincinnati Cornerstone Investors BWV I, LLC10 percent owner-J-OtherSell1,200,000--1,161,201
Jan 30, 2023Ramdeen Timothy R.director-A-AwardBuy2,386--2,386
Jan 17, 2023Ramdeen Timothy R.--Buy----
Jan 17, 2023Ramdeen Timothy R.director Buy----
Nov 21, 2022Cincinnati Cornerstone Investors BWV I, LLCdirector-J-OtherSell750,000--2,361,201
Nov 09, 2022Jeremic Vukdirector-A-AwardBuy3,610--3,610
Nov 08, 2022Jeremic Vuk--Buy----
Nov 08, 2022Jeremic Vukdirector Buy----
Aug 29, 2022Cincinnati Cornerstone Capital LLCdirector J-OtherSell500,000--3,111,201

The last insider sell of Onconetix's stock was made by Schiess Ralph on Jan 03 2024, selling - shares at - per share (valued at -).

Onconetix Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 202371700.00%
Q1 20231--
Q4 202211100.00%
Q3 20222540.00%
Q2 20227--
Q1 20221616.67%

7 total buy trades, and 1 total sell trades (buy/sell ratio of 7.00%) were made by Onconetix's insiders, as of Q2 2023.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2023---
Q1 2023---
Q4 2022---
Q3 2022-3-
Q2 2022---
Q1 2022---

As of Q2 2023, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Onconetix's stocks.

Onconetix Peer Ownership


TickerCompany
CDIOCardio Diagnostics Holdings, Inc.
BDRXBiodexa Pharmaceuticals Plc
VRAXVirax Biolabs Group Limited
QNRXQuoin Pharmaceuticals, Ltd.
PALIPalisade Bio, Inc.
PBLAPanbela Therapeutics, Inc.
KPRXKiora Pharmaceuticals, Inc.
UNCYUnicycive Therapeutics, Inc.
PXMDPaxMedica, Inc. Common Stock
REVBRevelation Biosciences, Inc.
HILSTharimmune, Inc.
ALLRAllarity Therapeutics, Inc.

BWV Ownership FAQ


Onconetix is owned by institutional shareholders (13.82%), insiders (17.69%), and public (68.49%). The largest institutional shareholder of Onconetix is RENAISSANCE TECHNOLOGIES LLC (0% of total shares) and the top mutual fund owner is VANGUARD INDEX FUNDS (0.00% of total shares).

Onconetix's major institutional shareholders are RENAISSANCE TECHNOLOGIES LLC, BANK OF NEW YORK MELLON CORP, CITADEL ADVISORS LLC, TWO SIGMA ADVISERS, LP, and O'DELL GROUP, LLC. The top five shareholders own together 0% of the company's share outstanding.

As of Dec 2023, there are 21 institutional shareholders of Onconetix.

RENAISSANCE TECHNOLOGIES LLC owns 0 shares of Onconetix, representing 0% of the company's total shares outstanding, valued at $0 (as of Mar 2024).

As of Mar 2024, BANK OF NEW YORK MELLON CORP holds 0 shares of Onconetix (BWV), compromising 0% of the company, valued at $0.

CITADEL ADVISORS LLC is the third largest holder of Onconetix. The company owns 0 of the company's shares outstanding (worth $0).